Biophile6 is an award winning small business person, chemist, biochemist, and microbiologist (Emory - Ph.D.; Harvard - Post Doc) with professional interest in clinical informatics, small business management, biotech valuation,and drug development. A former prep school chemistry instructor and cross country runner/skier, his professional goal is to organize the complex disciplines of drug compound identification and target validation, especially as regards bacterial and viral pathogens, for the purposes of clinical infection control, microbial pathogen surveillance, diagnostics, and vaccine development. Side interests include small business management, biofuels, metabolic pathway design, natural products chemistry, thorium nuclear, material coatings, transition metals and mining. He designs informatics algorithms, with an eye to devise new principles upon which to order research information meaningfully. These same principles governing the evolution of life can inform the evolution of companies.
17 years of investment experience in equities, bonds and options. A contrarian investor likes buying cheap and selling when the the security becomes "trendier". Very high historical returns. Owns the Israeli investment house Top Alpha Capital.
I manage my entire retirement portfolio with much success and my greatest success has come from my ability to find small undiscovered companies that only come along every so often. NQ and INO were my last two that handed me well over 300% gains in less than 6 months. Now it is NRTI, which is destined to be a 10,000% gainer in the next year! Cheers!